about
Lymphocyte activation-31P magnetic resonance studies of energy metabolism and phospholipid pathways.Two-dimensional 1H NMR studies of membrane changes during the activation of primary T lymphocytes.Proton magnetic resonance spectroscopy of lymphocytes: an historical perspective.Methods for studying Fc receptor expression.Characterization of FcR Ig-binding sites and epitope mapping.Generation of Human Monoclonal Autoantibody-Producing Cell Lines by Epstein-Barr Virus Transformation of Autoreactive B Lymphocytes and by Somatic Cell Hybridization Techniques: Application to the Analysis of the Autoimmune B Cell Repertoire.The enteric nervous and immune systems: interactions for mucosal immunity and inflammation.Use of complementary peptides and their antibodies in T-cell-mediated autoimmune disease: experiments with myelin basic protein.Isolation of CD34-positive hematopoietic progenitor cells.Ex vivo hematopoietic progenitor cell expansion.T-cell depletion and manipulation in allogeneic hematopoietic cell transplantation.Genetic marking and manipulation of hematopoietic progenitor cells using retroviral vectors.Peripheral blood progenitor cell transplantation for hematological malignancies.Detection of minimal residual disease in autologous grafts.Immunologically based methods for the elimination of tumor cells from autologous stem cell grafts.Liposomes for protein delivery: selecting manufacture and development processes.Liposomes as immunoadjuvants and vaccine carriers: antigen entrapment.Liposomes as carriers for vaccines.Endocytosis and presentation of liposome-associated antigens by B cells.Liposome-mediated cytoplasmic delivery of proteins: an effective means of accessing the MHC class I-restricted antigen presentation pathway.Immunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agents.Immunoliposomes in vivo.Systemic targeting of liposome-encapsulated immunomodulators to macrophages for treatment of cancer metastasis.Prolactin as a second messenger for interleukin 2.The role of the hypothalamic-pituitary-adrenal axis in susceptibility to autoimmune/inflammatory disease.Negative regulatory molecules in the neuroendocrine and immune systems: suppressin as an example.Theoretical and functional aspects of measuring insulin-like growth factor-I mRNA expression in myeloid cells.Complementary peptides that interfere with platelet aggregation and adherence.Antibodies to complementary peptides as probes for receptors.Complementary peptides as probes to explore neuropeptide receptors on lymphocytes.Nuclear magnetic resonance studies on complementary peptides.Heterogeneity of human IgG Fc receptors.Kinase activation through the high-affinity receptor for immunoglobulin E.Biological activities of murine low-affinity Fc receptors for IgG.Natural and recombinant soluble low-affinity Fc gamma R: detection, purification, and functional activities.Production and use of anti-FcR bispecific antibodies.High-resolution proton NMR studies of lymphocyte extracts.On-line studies of activation events in primary human T lymphocytes.Immobilization methods for NMR studies of cellular metabolism--a practical guide.Theoretical and practical aspects of NMR studies of cells.
P1433
Q34332625-1DE28304-7DE9-4C37-A47F-A018BEB6652DQ36738203-BF124890-D28F-43C8-B884-3354281BF288Q36738205-BCF05410-0589-449C-ABBD-01F3DF4C5C23Q38311670-302F4302-24D0-46C4-AE00-D9C933FF3170Q38311708-E931769C-1DE2-40B7-8BC7-41079DA628BDQ38676530-DD184BF0-A07F-4F63-9C2E-66484843A6E0Q40397306-FC2EFBAC-74A0-4F79-B074-243F2C7DF93BQ40398158-941DBCD5-66DA-404A-8E5F-EDBC69E096ABQ40401612-A82AFDC2-BD8C-424F-82A5-DD7D746D2C69Q40401617-10FAB17D-8662-4898-9F3E-828245739F89Q40544437-62D66205-E163-43B1-9978-28466B74ECB2Q40544448-D165DA5C-1EF3-4F91-8573-BC4B17C28522Q40544454-DDF80823-6C7F-4FEC-8DFA-BA6318E88958Q40544461-3AF94C31-E2AC-4890-8B59-BF3D7204191CQ40544467-3B62C0CC-BC65-4ECB-BCC8-08C7C6B82C8FQ40568739-76D2CB83-0D3E-4BA8-A4B6-BA196B90731BQ40568748-B45C5CBE-E720-4623-8DE3-80F1602C1BF3Q40568755-7216359D-9EE6-4FBC-9A8B-2C81B4E28896Q40568762-136FB3B3-954C-4DA1-BDDB-69FD357AB2E8Q40568770-523CBEB6-C0EE-4B02-97F2-028B039D3B42Q40568775-311415AC-A0AB-4822-A134-139A6CB8F98EQ40568780-3376C3B9-C4A8-4D23-A064-8D6A5C33D5CBQ40568785-2DEF06FF-849B-4DA7-9FEA-E1E868DB88FBQ40583250-1813F3D9-0C60-4BDB-895C-086434A4376DQ40583257-9F42E9A7-E592-4F91-A5FB-D2302F2D61E8Q40583262-EA44396D-8DD6-4A68-8EBD-BA1478952BB3Q40583268-3048D6CB-F2C9-469B-A6D6-C239BDDDFF1EQ40603371-7B2CB4CC-D28A-473B-9E24-7B25582CACAAQ40603378-A7A4128F-6C5F-482F-BD8E-688B5A54737EQ40603384-8CB30D2D-AF7A-4693-91CF-7486B59507AEQ40603389-9DE778C9-AF8E-4792-9C61-219788D5956AQ40693999-E4C51CFC-18EC-451F-A518-BDC5723AFE9BQ40694006-A54DF292-C1F4-45F8-A5C6-2CA731363CCAQ40694015-03BD0976-6A54-4191-B234-2285DC4E88B1Q40694021-EA0C04A5-EFDA-467A-98CE-6410A691E391Q40694025-F82BC976-F71C-49DF-A33C-082569A1D410Q40694028-E1768A19-8015-4E5E-849C-CA0C88618A91Q40694033-C5AD296A-6127-4971-B445-B27042F6C2BAQ40694042-89D39A5C-D3D5-4630-AA7A-14E17021DA8DQ40694050-574D710A-94CA-474A-9C87-33257917F2EA
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Academic Press
@nl
wissenschaftliche Fachzeitschrift
@de
name
ImmunoMethods
@ast
ImmunoMethods
@en
ImmunoMethods
@es
ImmunoMethods
@it
ImmunoMethods
@nl
type
label
ImmunoMethods
@ast
ImmunoMethods
@en
ImmunoMethods
@es
ImmunoMethods
@it
ImmunoMethods
@nl
altLabel
Immunomethods
@en
prefLabel
ImmunoMethods
@ast
ImmunoMethods
@en
ImmunoMethods
@es
ImmunoMethods
@it
ImmunoMethods
@nl
P1055
P1156
P123
P1476
ImmunoMethods
@en